未登录First-Line Lenvatinib plus Pembrolizumab for Hepatocellular Carcinoma: Post hoc Analysis of Japanese Patients from the Phase 3 LEAP-002 Trial一线伦伐替尼联合帕博利珠单抗治疗肝细胞癌：LEAP-002 III期试验中日本患者的事后分析
Ikeda, Masafumi; Aikata, Hiroshi; Numata, Kazushi; Marusawa, Hiroyuki; Hosaka, Tetsuya; Kato, Naoya; Morimoto, Manabu; Yamashita, Tatsuya; Koga, Hironori; Masaki, Tsutomu; Yatsuzuka, Naoyoshi; Suzuki, Masato; Nagao, Satoshi; Kaneko, Shuichi; Kumada, Hiromitsu .png)
分享.png)
收藏Newly established borderline resectable 1 (BR1) category is one of the favorable candidates for selecting the use of multidisciplinary combination therapy in patients with advanced hepatocellular carcinoma treated with systemic therapy新建立的边界可切除1 (BR1) 类别是选择使用多学科联合治疗的晚期肝细胞癌患者的有利候选人之一Kawamura, Yusuke; Akuta, Norio; Shindoh, Junichi; Matsumura, Masaru; Okubo, Satoshi; Tominaga, Licht; Yamamoto, Shigeki; Eriksson, Yasuka; Hosaka, Tetsuya; Saitoh, Satoshi; Sezaki, Hitomi; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Ikeda, Kenji; Arase, Yasuji; Hashimoto, Masaji; Kozuka, Takuyo; Kumada, Hiromitsu 分享 收藏 A new imaging classification for safer radial access visceral intervention of the liver and optimal case selection: A preliminary report一种用于更安全经桡动脉入路肝脏脏器介入治疗及优化病例选择的新影像学分类：初步报告Kawamura, Yusuke; Akuta, Norio; Fujiyama, Shunichiro; Hosaka, Tetsuya; Saitoh, Satoshi; Sezaki, Hitomi; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Ikeda, Kenji; Arase, Yasuji; Kumada, Hiromitsu 分享 收藏 HBcrAg-based risk score performs better than the HBV DNA-based scores for HCC prediction in grey zone patients who are HBeAg-negativeTseng, Tai-Chung; Hosaka, Tetsuya; Liu, Chun-Jen; Suzuki, Fumitaka; Chiang, Chieh; Hong, Chun-Ming; Kumada, Hiromitsu; Yang, Wan-Ting; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Kao, Jia-Horng 分享 收藏 A Phase 1b Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma: Extended Analysis of Study 116Kudo, Masatoshi; Finn, Richard S.; Ikeda, Masafumi; Sung, Max W.; Baron, Ari D.; Okusaka, Takuji; Kobayashi, Masahiro; Kumada, Hiromitsu; Kaneko, Shuichi; Pracht, Marc; Meyer, Tim; Nagao, Satoshi; Saito, Kenichi; Mody, Kalgi; Ramji, Zahra; Dubrovsky, Leonid; Llovet, Josep M. 分享 收藏 Clinical outcome after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients who achieved HBsAg seroclearanceSuzuki, Fumitaka; Hosaka, Tetsuya; Suzuki, Yoshiyuki; Sezaki, Hitomi; Akuta, Norio; Fujiyama, Shunichiro; Kawamura, Yusuke; Saitoh, Satoshi; Arase, Yasuji; Kobayashi, Mariko; Kumada, Hiromitsu 分享 收藏 Impact of genetic polymorphism on personalized diet and exercise program for steatotic liver disease基因多态性对个性化饮食和运动计划对脂肪性肝病的影响Akuta, Norio; Kawamura, Yusuke; Fujiyama, Shunichiro; Nakamichi, Kenichi; Saegusa, Eiji; Ogura, Hidetoshi; Kato, Masaki; Doi, Etsuko; Inoue, Naoko; Sezaki, Hitomi; Hosaka, Tetsuya; Kobayashi, Mariko; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Suzuki, Yoshiyuki; Kumada, Hiromitsu; Suzuki, Fumitaka 分享 收藏 Impact of fibrosis on liver-related event incidence in nonalcoholic fatty liver disease: A multicenter observational study肝纤维化对非酒精性脂肪性肝病患者肝脏相关事件发生率的影响: 一项多中心观察性研究Chayama, Kazuaki; Hiramatsu, Akira; Shima, Toshihide; Itoh, Yoshito; Yamaguchi, Kanji; Nakajima, Tomoaki; Hoshikawa, Kyoko; Kawamura, Yusuke; Akuta, Norio; Ito, Kiyoaki; Kawanaka, Miwa; Sakamoto, Michiie; Harada, Kenichi; Goto, Yoshihito; Nakayama, Takeo; Kumada, Hiromitsu; Okanoue, Takeshi 分享 收藏 Treatment efficacy of diet and exercise program for fatty liver and pretreatment predictors脂肪肝饮食与运动干预方案的治疗效果及治疗前预测因子Akuta, Norio; Kawamura, Yusuke; Fujiyama, Shunichiro; Nakamichi, Kenichi; Saegusa, Eiji; Ogura, Hidetoshi; Kato, Masaki; Doi, Etsuko; Inoue, Naoko; Sezaki, Hitomi; Hosaka, Tetsuya; Kobayashi, Mariko; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Suzuki, Yoshiyuki; Kumada, Hiromitsu; Suzuki, Fumitaka 分享 收藏 Phase IIa, randomised, double-blind study of GSK3389404 in patients with chronic hepatitis B on stable nucleos(t)ide therapyGSK3389404在稳定核苷 (酸) ide治疗慢性乙型肝炎患者中的IIa期，随机，双盲研究Yuen, Man-Fung; Heo, Jeong; Kumada, Hiromitsu; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Xie, Qing; Jia, Jidong; Karino, Yoshiyasu; Hou, Jinlin; Chayama, Kazuaki; Imamura, Michio; Lao-Tan, Judy Y.; Lim, Seng Gee; Tanaka, Yasuhito; Xie, Wen; Yoon, Jung-Hwan; Duan, Zhongping; Kurosaki, Masayuki; Park, Sung-Jae; Labio, Madalinee Eternity; Kumar, Rajneesh; Kweon, Young-Oh; Yim, Hyung Joon; Tao, Yu; Cremer, Jennifer; Elston, Robert; Davies, Matt; Baptiste-Brown, Sharon; Han, Kelong; Campbell, Fiona M.; Paff, Melanie; Theodore, Dickens 分享 收藏 Sofosbuvir-velpatasvir in adults with hepatitis C virus infection and compensated cirrhosis in JapanTakehara, Tetsuo; Izumi, Namiki; Mochida, Satoshi; Genda, Takuya; Fujiyama, Shigetoshi; Notsumata, Kazuo; Tamori, Akihiro; Suzuki, Fumitaka; Suri, Vithika; Mercier, Renee-Claude; Matsuda, Takuma; Matsuda, Kana; Kato, Naoya; Chayama, Kazuaki; Kumada, Hiromitsu 分享 收藏 Impact of bodyweight-based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinomaOkusaka, Takuji; Kudo, Masatoshi; Ikeda, Kenji; Ikeda, Masafumi; Okita, Kiwamu; Sugawara, Michiko; Tamai, Toshiyuki; Ren, Min; Saito, Kenichi; Kumada, Hiromitsu 分享 收藏 Molecular signatures of long-term hepatocellular carcinoma risk in nonalcoholic fatty liver diseaseFujiwara, Naoto; Kubota, Naoto; Crouchet, Emilie; Koneru, Bhuvaneswari; Marquez, Cesia A.; Jajoriya, Arun K.; Panda, Gayatri; Qian, Tongqi; Zhu, Shijia; Goossens, Nicolas; Wang, Xiaochen; Liang, Shuang; Zhong, Zhenyu; Lewis, Sara; Taouli, Bachir; Schwartz, Myron E.; Fiel, Maria Isabel; Singal, Amit G.; Marrero, Jorge A.; Fobar, Austin J.; Parikh, Neehar D.; Raman, Indu; Li, Quan-Zhen; Taguri, Masataka; Ono, Atsushi; Aikata, Hiroshi; Nakahara, Takashi; Nakagawa, Hayato; Matsushita, Yuki; Tateishi, Ryosuke; Koike, Kazuhiko; Kobayashi, Masahiro; Higashi, Takaaki; Nakagawa, Shigeki; Yamashita, Yo-ichi; Beppu, Toru; Baba, Hideo; Kumada, Hiromitsu; Chayama, Kazuaki; Baumert, Thomas F.; Hoshida, Yujin 分享 收藏 Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study长期SGLT2抑制剂对合并糖尿病的NAFLD患者的有利影响: 一项5年随访研究Akuta, Norio; Kawamura, Yusuke; Fujiyama, Shunichiro; Saito, Satoshi; Muraishi, Nozomu; Sezaki, Hitomi; Hosaka, Tetsuya; Kobayashi, Masahiro; Kobayashi, Mariko; Arase, Yasuji; Ikeda, Kenji; Suzuki, Fumitaka; Suzuki, Yoshiyuki; Kumada, Hiromitsu 分享 收藏 Molecular Signature Predictive of Long-Term Liver Fibrosis Progression to Inform Antifibrotic Drug Development预测长期肝纤维化进展的分子特征，以告知抗纤维化药物的开发Qian, Tongqi; Fujiwara, Naoto; Koneru, Bhuvaneswari; Ono, Atsushi; Kubota, Naoto; Jajoriya, Arun K.; Tung, Matthew G.; Crouchet, Emilie; Song, Won-Min; Marquez, Cesia Ammi; Panda, Gayatri; Hoshida, Ayaka; Raman, Indu; Li, Quan-Zhen; Lewis, Cheryl; Yopp, Adam; Rich, Nicole E.; Singal, Amit G.; Nakagawa, Shigeki; Goossens, Nicolas; Higashi, Takaaki; Koh, Anna P.; Bian, C. Billie; Hoshida, Hiroki; Tabrizian, Parissa; Gunasekaran, Ganesh; Florman, Sander; Schwarz, Myron E.; Hiotis, Spiros P.; Nakahara, Takashi; Aikata, Hiroshi; Murakami, Eisuke; Beppu, Toru; Baba, Hideo; Warren, Rew; Bhatia, Sangeeta; Kobayashi, Masahiro; Kumada, Hiromitsu; Fobar, Austin J.; Parikh, Neehar D.; Marrero, Jorge A.; Rwema, Steve Hategekimana; Nair, Venugopalan; Patel, Manishkumar; Kim-Schulze, Seunghee; Corey, Kathleen; O'Leary, Jacqueline G.; Klintmalm, Goran B.; Thomas, David L.; Dibas, Mohammed; Rodriguez, Gerardo; Zhang, Bin; Friedman, Scott L.; Baumert, Thomas F.; Fuchs, Bryan C.; Chayama, Kazuaki; Zhu, Shijia; Chung, Raymond T.; Hoshida, Yujin 分享 收藏 Serum TERT C228T is an important predictor of non-viral liver cancer with fatty liver disease血清TERT C228T是非病毒性肝癌合并脂肪肝的重要预测指标Akuta, Norio; Kawamura, Yusuke; Suzuki, Fumitaka; Kobayashi, Mariko; Arase, Yasuji; Saitoh, Satoshi; Muraishi, Nozomu; Fujiyama, Shunichiro; Sezaki, Hitomi; Hosaka, Tetsuya; Kobayashi, Masahiro; Suzuki, Yoshiyuki; Ikeda, Kenji; Kumada, Hiromitsu 分享 收藏 The useful predictors of zinc deficiency for the management of chronic liver disease锌缺乏对慢性肝病管理的有用预测因子Iritani, Soichi; Kawamura, Yusuke; Muraishi, Nozomu; Fujiyama, Shunichiro; Sezaki, Hitomi; Hosaka, Tetsuya; Akuta, Norio; Kobayashi, Masahiro; Saitoh, Satoshi; Suzuki, Fumitaka; Arase, Yasuji; Ikeda, Kenji; Suzuki, Yoshiyuki; Kumada, Hiromitsu 分享 收藏 Hepatitis B Core-Related Antigen Stratifies the Risk of Liver Cancer in HBeAg-Negative Patients With Indeterminate PhaseTseng, Tai-Chung; Hosaka, Tetsuya; Liu, Chun-Jen; Suzuki, Fumitaka; Hong, Chun-Ming; Kumada, Hiromitsu; Yang, Wan-Ting; Hsu, Chen-Yang; Su, Tung-Hung; Yang, Hung-Chih; Liu, Chen-Hua; Chen, Pei-Jer; Chen, Hsiu-Hsi; Kao, Jia-Horng 分享 收藏 Renal safety and biochemical changes for 2 years after switching to tenofovir alafenamide from long-term other nucleotide analog treatment in patients with chronic hepatitis B慢性乙型肝炎患者长期其他核苷酸类似物治疗改用替诺福韦艾拉酚胺后2年的肾脏安全性和生化变化Hosaka, Tetsuya; Suzuki, Fumitaka; Kobayashi, Masahiro; Fujiyama, Shunichirou; Kawamura, Yusuke; Sezaki, Hitomi; Akuta, Norio; Suzuki, Yoshiyuki; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu 分享 收藏 Effectiveness of tenofovir alafenamide for chronic hepatitis B patients with a poor response to the previously used nucleos(t)ide analogs替诺福韦艾拉酚胺对既往核苷（酸）类似物治疗效果不佳的慢性乙型肝炎患者的疗效Yamashige, Daiki; Hosaka, Tetsuya; Suzuki, Fumitaka; Fujiyama, Shunichiro; Kawamura, Yusuke; Sezaki, Hitomi; Akuta, Norio; Kobayashi, Masahiro; Suzuki, Yoshiyuki; Saitoh, Satoshi; Arase, Yasuji; Ikeda, Kenji; Kobayashi, Mariko; Kumada, Hiromitsu 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png)
HEPATOLOGY RESEARCH.png)
